Chinese Sinovac “confident” in vaccine despite suspension of trial in Brazil

Photo of author

By admin

Beijing | Chinese laboratory Sinovac Biotech said Tuesday it was confident in the safety of its experimental vaccine against COVID-19 despite the suspension of a clinical trial in Brazil following a “serious incident”.

“We are confident in the safety of the vaccine,” Sinovac said in a statement, saying the incident in question was “unrelated” to the vaccine.

The Brazilian Health Vigilance Agency (Anvisa) announced on Monday that it had decided to stop the clinical trial of Sinovac’s CoronaVac vaccine after a “serious” incident that occurred on October 29.

She did not provide details of what happened, but indicated that these types of incidents could include death, potentially fatal side effects, severe disability, hospitalization and other “clinically significant events.” “.

The public body that coordinates vaccine trials in Brazil, the Butantan Institute, said it was “surprised” by this decision. He will give a press conference on the subject on Tuesday (2 p.m. GMT).

The shutdown for CoronaVac came the same day that US pharmaceutical giant Pfizer announced that its coronavirus vaccine had reached 90% effectiveness.

Leave a Comment